Paul Gibeault, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 30 Airport Rd, S Burlington, VT 05403 Phone: 802-658-3924 Fax: 802-658-0216 |
Tina L Bleau, M.A. Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 30 Airport Rd, S Burlington, VT 05403 Phone: 802-658-3924 Fax: 802-658-0216 |
Julia Anne Camuso, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 56 W Twin Oaks Ter Ste 5, S Burlington, VT 05403 Phone: 802-880-3001 |
Joelle Palmer Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 30 Airport Rd, S Burlington, VT 05403 Phone: 802-658-3924 Fax: 802-658-0216 |
Dr. Carolyn Rushford, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 366 Dorset St, Suite 10, S Burlington, VT 05403 Phone: 802-654-7607 |
Cara M. Capparelli, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 30 Airport Rd, S Burlington, VT 05403 Phone: 802-658-3924 Fax: 802-658-0216 |
Richard Wolak, MA Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 30 Airport Rd, S Burlington, VT 05403 Phone: 802-658-0040 |
News Archive
In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.
The effect of visit-to-visit blood pressure variability on mortality may be partly caused by changes in average values over time, say researchers.
The following is GlaxoSmithKline's statement regarding recommendations of a combined Advisory Committee to the FDA on the use of asthma medicines containing long-acting beta agonists, including GSK's Serevent (salmeterol) and Advair (salmeterol/fluticasone proprionate).
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
› Verified 8 days ago